Rein Therapeutics(RNTX) Stock Price Today

US Stock MarketDetailed Quotes

Rein Therapeutics (RNTX)

Watchlist

0.938
-0.082-8.03%

Trading Jun 5 15:24 ET

80.24MMarket Cap-0.49P/E (TTM)

RNTX Stock Chart

Real-Time

5D
Daily
Weekly
Monthly
1Q
1Y

RNTX Orderflow

Unit: --

RNTX Orderflow Trend

IntradayDayWeekMonth

No Data

Rein Therapeutics (RNTX) News

12 Health Care Stocks Moving In Monday's After-Market Session
BenzingaJun 1 17:06 ET
H.C. Wainwright Maintains Rein Therapeutics(RNTX.US) With Buy Rating, Cuts Target Price to $8
Moomoo NewsJun 1 06:31 ET · Ratings
Rein Therapeutics Price Target Lowered to $8 From $10 at H.C. Wainwright
TipRanksJun 1 06:00 ET
Insider Purchase: Director at $RNTX Buys 23,190 Shares
Quiver QuantitativeMay 28 20:31 ET
Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option
GlobeNewswireMay 18 08:00 ET
Express News | Rein Therapeutics Q1 EPS $(0.19) Beats $(0.49) Estimate
BenzingaMay 15 09:27 ET

Rein Therapeutics (RNTX) Stock Forum

Trytosaveabit

May 1 08:32

news

$Rein Therapeutics (RNTX.US)$ Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock
GlobeNewswire
31m
AUSTIN, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics, Inc. ("Rein" or the "Company") (NASDAQ: RNTX), a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class medicines for orphan pulmonary and fibrosis indications, today announced the pricing of its underwritten public offering of fifty million shares of i...

newbiessss

Apr 6 23:33

$Rein Therapeutics (RNTX.US)$ buy boyzzz?? 1.47

Trytosaveabit

Jan 20 21:04

news

$Rein Therapeutics (RNTX.US)$ Reuters
4m
Rein Therapeutics Receives Orphan Drug Designation From European Medicines Agency for Lead Drug Candidate in Idiopathic Pulmonary Fibrosis